UnitedHealth Group (UNH) FY2024 10-K Annual Report
UnitedHealth Group (UNH) 10-K annual report for fiscal year 2024, filed with SEC EDGAR on Feb 27, 2025. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
UnitedHealth Group FY2024 10-K Analysis
Business Overview
- • Core business model: Diversified healthcare services including insurance and health benefits administration
- • No new products, services, or segments introduced or emphasized in this filing
- • Continued emphasis on corporate governance and executive ethics via updated Code of Conduct and disclosures on website
- • Equity compensation plans include 17 million shares exercisable, $370 weighted-average exercise price, 64 million shares available for future issuance as of 12/31/2024
- • Noteworthy: Inclusion of detailed stock incentive plan data, with no future awards under acquired plans, reflecting focus on equity management
Management Discussion & Analysis
- • Change Healthcare cyberattack: $2.2B direct response costs, $867M Optum Insight revenue disruption in 2024, $9B interest-free loans provided through 2024
- • Medical costs impact: $640M related to care management suspension in 2024 affecting UnitedHealthcare and Optum Health
- • Increased care patterns and inflation driving higher medical costs, with hospital coding intensity and high-cost drug prescribing upstrift ongoing
- • Medicaid redeterminations reduced Medicaid enrollment, partially offset by commercial growth; rate mismatches expected to narrow in 2025
- • Regulatory and payment shifts driving transition to value-based care; investing in technology and care coordination to support growth in Optum segments
Risk Factors
- • Legal risk from ongoing False Claims Act investigations and potential substantial penalties due to healthcare benefits coverage and claims payment disputes
- • Macroeconomic exposure to medical cost inflation, pandemic effects, drug price increases threatening profitability of risk-based products constituting ~80% of revenues
- • Cybersecurity vulnerability exemplified by 2024 Change Healthcare cyberattack exposing protected health information, risking costly data breaches and operational interruptions
- • Competitive risk from consolidation among healthcare providers and payers reducing bargaining power, affecting provider network contracts and pricing models
- • Integration risk of acquired businesses with different IT system vulnerabilities and litigation profiles potentially undermining operational synergies and increasing costs
UnitedHealth Group FY2024 Key Financial MetricsXBRL
Revenue
$400.3B
▲ +7.7% YoY
Net Income
$14.4B
▼ -35.6% YoY
Operating Margin
8.1%
▼ -64bp YoY
Net Margin
3.6%
▼ -242bp YoY
ROE
14.7%
▼ -904bp YoY
Total Assets
$298.3B
▲ +9.0% YoY
EPS (Diluted)
$15.51
▼ -35.0% YoY
Operating Cash Flow
$24.2B
▼ -16.7% YoY
Source: XBRL data from UnitedHealth Group FY2024 10-K filing on SEC EDGAR. All figures in USD.
Other UnitedHealth Group Annual Reports
Get deeper insights on UnitedHealth Group
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.